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Abstract 
Background 
Hand surgery dogma suggests that simultaneous surgical treatment of carpal tunnel syndrome 
(CTS) and Dupuytren's contracture (DC) results in an increased incidence of Complex Regional 
Pain Syndrome (CRPS). As a result, many surgeons do not perform surgery for the two 
conditions concurrently.  Our goal was to determine the extent of this association. 
Methods 
We identified all patients undergoing surgical treatment for CTS, DC, or both between April 
1982 and March 2017 using the Indiana Network for Patient Care (INPC), a large, multi-
institutional, statewide information exchange. Demographics, comorbidities, and 1-year post-
operative incidence of CRPS were recorded.  
Results 
A total of 51,739 (95.6%) patients underwent carpal tunnel release (CTR) only, 2,103 (3.9%) 
underwent palmar fasciectomy (PF) only, and 305 (0.6%) underwent concurrent CTR and PF.  
There was no difference in the likelihood of developing CRPS (p=0.163) between groups.  
Independent risk factors for developing CRPS were younger age, anxiety, depression, epilepsy, 
gout, and history of fracture of the radius, ulna, or the carpus.   
Conclusions 
Concurrent CTR and PF is not associated with an increased risk for developing CRPS.  Patient 
demographics, medical comorbidities, and a history of upper extremity trauma are associated 
with the development of CRPS after surgery and should be discussed preoperatively as potential 
risk factors.   
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Introduction 
 Complex regional pain syndrome (CRPS) is a chronic, debilitating syndrome 
characterized by pain, trophic changes, and autonomic dysfunction that can occur after minor 
upper extremity trauma or surgery[1, 2].  It has been reported to occur after common procedures 
in hand surgery, such as those used to treat carpal tunnel syndrome (CTS)[3] and Duyputren’s 
contracture (DC)[4]. CTS and DC can occur simultaneously and surgeons may have to consider 
concurrent surgical treatment. 
 Early observational studies of concurrent surgical treatment of CTS and DC suggest that 
there is an increased risk for developing CRPS[5, 6].  A recent meta-analysis, however, suggests 
that this increased risk may be smaller than previously thought[7].  Despite this, a survey of hand 
surgeons demonstrated that only half would be willing to perform surgical treatment of each 
condition simultaneously, given the concerns for development of CRPS[8].   
The primary aim of this study is to assess whether simultaneous surgical treatment of DC 
and CTS results in an increased incidence of CRPS.  Further, we sought to determine if other 
patient-related variables previously identified as risk factors for CRPS[9, 10] contribute to the 
development of CRPS after surgery.     
Methods 
Data Source 
A database of unique, de-identified patients was built from the Indiana Network for 
Patient Care (INPC) using all patients who underwent treatment for DC or CTS from April 16, 
1982 through March 27, 2017.  The predecessor to the INPC was developed in 1972 as an 
electronic medical record; this evolved into a multi-institutional health information exchange 
containing longitudinal patient data throughout the continuum of inpatient and outpatient 
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healthcare in multiple settings, including outpatient surgery centers, predominantly in the state of 
Indiana[11-13].   Further, the majority of health care institutions in the state of Indiana 
participate in the INPC[14].   Each patient is assigned a unique global identifier and an algorithm 
is used to match patients with their health data based on associated unique identifiers, such as 
name, birth date, and demographic information[15].  Data are imported in real time directly from 
each institution’s proprietary electronic medical record systems, and are subsequently validated 
by comparison to with insurance claims, billing submissions, operative reports, public health 
records, and pharmacy records. Data is reviewed by a clinical data analyst and provided by the 
Regenstreif Institute for research purposes[16]. The INPC currently includes data from over 38 
health systems with greater than 13 million patients and 11 billion clinical data elements.   
Patient Sample and Variables 
Patients were divided into three cohorts—those who underwent CTR only (Current 
Procedural Terminology (CPT) codes 64721 or 29848), PF only (either CPT 26125, 26123, 
26121, or 26045), or both CTR and PF during the same encounter.  The diagnosis of CRPS, 
based on International Classification of Disease (ICD) codes (ICD-9 337.21, 354.4, 337.20; ICD-
10 G56.4, G90.50, G90.51, G90.511, G90.512, G90.513, G90.519, G90.59), within one year of 
surgery was recorded.  Comorbidities previously reported to be risk factors for CRPS were also 
recorded. Patient data were stored and analyzed using Indiana University Cloud computing and 
Microsoft Excel (Redmond, Washington, USA) in compliance with the Health Insurance 
Portability and Accountability Act of 1996 (HIPAA).  All procedures followed were in 
accordance with the ethical standards of the Institutional Review Board of Indiana University. 
Statistics 
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Univariate analyses were conducted to describe the population sample. Chi-square tests 
and Fisher’s exact tests were computed to report the bivariate relationships between variables. To 
examine the extent of bivariate relationships, we calculated odds ratio with 95% confidence 
intervals and p-values using simple logistic regressions.  To examine the relationship between 
different surgical treatments and CRPS we used multivariable logistic regression analysis 
controlling for the effect of sex, race, age, and comorbidities. Statistical analyses were conducted 
at 0.05 level of significance using Stata/SE 14.2 software (College Station, Texas, USA). 
Results 
A total of 54,147 patients met inclusion criteria; 51,739 (95.6%) underwent CTR only, 
2,103 (3.9%) underwent PF only, and 305 (0.6%) underwent concurrent surgery.  Table 1 
illustrates demographic differences between groups.  Those undergoing concurrent surgery were 
more likely to be male and white. Comorbidities were most prevalent in patients undergoing 
concurrent surgery and least prevalent in patients undergoing PF (Table 2). Diabetes, epilepsy, 
hypercholesterolemia, hyperlipidemia, osteoarthritis, and radius or ulna fractures were most 
common in patients undergoing concurrent surgery. 
CRPS occurred in 298 patients (0.58%) after CTR only, 7 patients (0.33%) after PF only, 
and 3 patients (0.98%) who underwent concurrent surgery. There was no statistically significant 
difference in the risk for CRPS based on surgical group (p=0.163, and Table 3).  Type of surgery 
within each group also did not significantly increase the risk of developing CRPS (See Table, 
Supplemental Digital Content 1, which shows the 1 year incidence of CRPS based on CPT 
code); specifically, endoscopic carpal tunnel release had the same risk for developing CRPS as 
open carpal tunnel release.  Female sex, alcohol abuse, anxiety, depression, epilepsy, gout, radius 
or ulna fracture, wrist fracture, and wrist sprain were risk factors for CRPS in bivariate analysis.  
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On multivariable analysis, independent risk factors for CRPS were younger age, anxiety, 
depression, epilepsy, gout, radius or ulna fracture, and wrist fracture (Table 4).  Having any 
comorbid condition increased the likelihood of CRPS 3.31 times (p<0.001).  The average age of 
patients developing post-operative CRPS was 47.9 (±12.0) years, compared to 51.5 (±14.7) years 
for patients who did not develop CRPS (p<0.001).  Multivariable analysis yielded similar results 
after applying a variable selection procedure (See Table, Supplemental Digital Content 2, which 
shows adjusted risk factors for developing CRPS after using a stepwise logistic regression to 
determine only variables whose p-values are ≤0.10). 
Discussion 
Many hand surgeons avoid simultaneous surgical treatment of CTS and DC because of 
concerns regarding development of CRPS[8].  In this study, we have shown that simultaneous 
CTR and PF does not increase the risk for developing CRPS. Thus, surgeons may consider 
performing the procedures concurrently without placing the patient at an increased risk for 
postoperative pain sequelae. 
Rather than the type of surgery, we found that comorbidities were the best predictors for 
development of CRPS.  Anxiety and depression were risk factors for CRPS in this study. This 
may be due to a shared neuropathophysiology, as similar brain regions are affected in CRPS[17, 
18], depression[19, 20], and generalized anxiety disorder[21, 22].  Others have also shown that 
anxiety and anxious traits are risk factors for developing CRPS[17, 18, 23, 24], although this is 
controversial[25].  Abnormal neural functioning and pathways in the central nervous system 
being central to the pathogenesis of CRPS[26] may account for this and other studies[10, 27] 
finding epilepsy as a risk factor for CRPS. Understanding the neuropsychological profile of 
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patients most likely to develop CRPS allows the surgeon to identify at-risk patients during the 
initial consultation. 
We found a statistically significant inverse correlation between age and incidence of post-
operative CRPS.  There is disagreement in the literature regarding age as a risk factor for CRPS.  
Some studies show increased age increases the risk for CRPS, other studies show decreasing age 
is a risk factor for CRPS, and yet other studies shows no correlation[9].  As one ages, the ability 
to develop new pathologic neuronal connections decreases and this may provide a modest level 
of protection against the development of CRPS.  Further research is necessary to confirm the role 
of neuronal plasticity as it relates to CRPS. 
Systemic disease has been inconsistently associated with an increased risk for developing 
CRPS.  In this study, we found hyperlipidemia, hypercholesterolemia, and gout to be 
independent risk factors for CRPS.  Hyperlipidemia was a risk factor for CRPS in some 
studies[28, 29], involved only in the initial stages of the disease in another[30], and unrelated in 
other studies[10, 30-32].  A mechanism by which hyperlipidemia may predispose the 
development of CRPS is by increasing the substrate used to synthesize pro-inflammatory 2-series 
prostanoids, 4-series leukotrienes, and other mediators of inflammation, vasomotor changes, and 
pain[28, 33, 34].  This hypothesis is supported by empiric data demonstrating that certain lipid 
derivatives are elevated in the serum of patients with CRPS compared with healthy controls[28, 
35].  Hypercholesterolemia similarly has been inconsistently associated with the development of 
CRPS in other studies[10, 29, 36].  Lastly, our data is consistent with other research indicating an 
association between CRPS, elevated uric acid levels[29], and acute post-operative gout[37, 38]. 
In the majority of cases of CRPS, localized trauma is reported as the inciting event.  We 
found that prior fracture of the radius, ulna, or wrist are independent risk factors for development 
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of CRPS; this is consistent with previously published data[10, 39].  Several theories regarding 
the pathophysiology of CRPS exist. Perhaps the most well accepted theory is that of a tissue or 
nerve injury causing aberrant release of chemical mediators in the susceptible individual. This, in 
turn, leads to maladaptive changes in the nervous and vascular systems[40].  These changes may 
cause immediate development of CRPS or predispose to future development with subsequent 
trauma[41].  This theory accounts for our findings of prior fracture of the radius, ulna, or wrist as 
independent risk factors for development of CRPS after surgery.  
Whereas generalizability is a concern with all state-based patient registries, our patient 
demographics are consistent with those published in previous studies.  Others have shown that 
DC is more prevalent in older, white male patients[42, 43] and CTS is more prevalent in 
younger, female patients[8, 44].  Further, consistent with other studies, we found that concurrent 
surgery is more frequently performed in males[5] and concurrent surgery patients are generally 
older than CTS patients[8].   
Our study has several limitations related to the data source and the retrospective nature of 
the review. Patient attrition and missing data remain a concern with large databases and internal 
quality is difficult to confirm. For example, patient race was not reported by several institutions 
and this limited our demographic assessment. We attempted to minimize biases due to patient 
dropout and missing data by only including patients that had an INPC encounter before and after 
the study period.   As a database built from input throughout the continuum of healthcare, there 
may be errors in diagnosis and procedural coding.  The INPC mitigates this risk by comparing 
codes input directly by healthcare providers with those submitted for billing and insurance 
claims [13-15].  Finally, this study does not investigate complications other than CRPS after 
concurrent CTR and PF, yet these findings may be clinically significant.    
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Conclusion 
This study demonstrates that concurrent CTR and PF does not increase the likelihood for 
developing CRPS.  Factors associated with CRPS after surgery for CTS and DC include younger 
age, anxiety, depression, epilepsy, gout, and forearm and wrist fractures. Based on these data, we 
recommend simultaneous surgery for patients with CTS and DC after an informed discussion of 
the likelihood for CRPS in the at-risk population.  
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Supplemental Digital Content Legends 
Table, Supplemental Digital Content 1, which shows the influence of type of surgery for 
CTR and PF on developing CRPS. The 1-year postoperative incidence of CRPS based on CPT 
code is shown, INSERT HYPER LINK. 
Table, Supplemental Digital Content 2, which shows the adjusted Risk Factors for 
Developing CRPS after Surgery Using Variable Selection.  A stepwise logistic regression was 
used to determine only the variables whose p-values are ≤0.10, except forcing type of surgery 
into the model, INSERT HYPER LINK. 
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Table 1.  Patient Demographics  
  Carpal Tunnel Release   Palmar Fasciectomy  Concurrent Surgery 
 Patients (%) p  Patients (%) p  Patients (%) p 
Sex         
   Female 35,266 (68.4) <0.001  658 (31.4) <0.001  146 (48.0) <0.001 
   Male 16,305 (31.6)   1,440 (68.6)   158 (52.0)  
Race         
   White 18,386 (85.6) 0.001  502 (89.5) 0.011  119 (93.7) 0.013 
   Non-white 3,092 (14.4)   59 (10.5)   8 (6.3)  
Age (years)         
   Mean (±SD) 51.2 (±14.6)   58.3 (±14.0)   57.9 (±11.7)  
SD, Standard deviation.   
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Table 2. Patient Comorbidities  
 CTR Only PF Only Concurrent Surgery 
 Patients (%) Patients (%) Patients (%) 
Alcohol abuse 3,448 (6.7) 162 (7.7) 27 (8.9)    
Anxiety 10,235 (19.8) 229 (10.9) 62 (20.3) 
Depression 22,638 (43.8) 558 (26.5) 128 (42.0) 
Diabetes 19,357 (37.4) 714 (34.0) 146 (47.9) 
Epilepsy 2,568 (5.0) 72 (3.4) 24 (7.9) 
Fibromyalgia 1,235 (2.4) 15 (0.7) 4 (1.3) 
Gout 3,695 (7.1) 157 (7.5) 25 (8.2) 
Hypercholesterolemia 17,424 (33.7) 733 (34.9) 137 (44.9) 
Hyperlipidemia 33,100 (64.0) 1429 (68.0) 235 (77.1) 
Hyperparathyroidism 822 (1.6) 18 (0.9) 6 (2.0) 
Multiple Sclerosis 731 (1.4) 6 (0.3) 3 (1.0) 
Osteoarthritis 28,758 (55.6) 928 (44.1) 200 (65.6) 
Finger fracture 1,571 (3.0) 62 (3.0) 12 (3.9) 
Hand fracture 1,085 (2.1) 43 (2.0) 8 (2.6) 
Radius or Ulnar fracture 3,249 (6.3) 81 (3.9) 29 (9.5) 
Wrist fracture 1560 (3.0) 31 (1.5) 6 (2.0) 
Wrist sprain 3,488 (6.7) 62 (3.0) 23 (7.5) 
Any comorbidities 45,770 (88.5) 1786 (84.9) 284 (93.1) 
CTR, carpal tunnel release; PF, palmar fasciectomy  
AC
CE
PT
ED
18 
 
Table 3. Risk Factors for Developing Complex Regional Pain Syndrome after Surgery 
 Patients (%) OR [95% CI] p 
Type of Surgery    
   CTR only 298 (0.58)   
   PF only 7 (0.33) 0.58 [0.27, 1.22] 0.15 
   Concurrent Surgery 3 (0.98) 1.71 [0.55, 5.38] 0.355 
Sex    
   Female 224 (0.62) 1.33 [1.03, 1.7] 0.028 
   Male 84 (0.47) 
  Race 
      White 127 (0.67) 0.81 [0.53, 1.24] 0.331 
   Non-white 26 (0.82) 
  Comorbidity 
   Alcohol Abuse 38 (1.04) 1.96 [1.40, 2.76] <0.001 
   Anxiety 108 (1.03) 2.25 [1.78, 2.85] <0.001 
   Depression 197 (0.84) 2.36 [1.87, 2.98] <0.001 
   Diabetes 124 (0.61) 1.13 [0.90, 1.42] 0.288 
   Epilepsy 33 (1.24) 2.34 [1.62, 3.36] <0.001 
   Fibromyalgia 10 (0.80) 1.42 [0.75, 2.67] 0.278 
   Gout 35 (0.90) 1.67 [1.17, 2.38] 0.005 
   Hypercholesterolemia 101 (0.55) 0.96 [0.75, 1.21] 0.712 
   Hyperparathyroidism 3 (0.35) 0.62 [0.20, 1.93] 0.408 
   Multiple Sclerosis 7 (0.95) 1.68 [0.79, 3.58] 0.174 
   Osteoarthritis 187 (0.63) 1.26 [1.00, 1.58] 0.051 
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OR, odds ratio; 95% CI, 95% confidence interval.  
   Finger fracture 10 (0.61) 1.07 [0.57, 2.02] 0.831 
   Hand fracture 9 (0.79) 1.41 [0.72, 2.74] 0.314 
   Radius or Ulna fracture 38 (1.13) 2.14 [1.52, 3.01] <0.001 
   Wrist fracture 24 (1.50) 2.81 [1.85, 4.27] <0.001 
   Wrist sprain 41 (1.15) 2.19 [1.57, 3.04] <0.001 
   Any comorbidities 295 (0.62) 3.00 [1.72, 5.24] <0.001 
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Table 4. Adjusted Risk Factors for Developing Complex Regional Pain Syndrome after Surgery 
 Adjusted OR [95% CI] p 
Type of Surgery   
   CTR only   
   PF only 0.807 [0.377-1.728] 0.581 
   Concurrent Surgery 1.854 [0.586-5.865] 0.293 
Sex   
   Male   
   Female 1.076 [0.826-1.402] 0.587 
Race   
   Non-white   
   White 0.741 [0.482-1.137] 0.170 
Age 0.987 [0.978-0.997] 0.008 
Comorbidities   
   Alcohol abuse 1.237 [0.861-1.778] 0.249 
   Anxiety 1.498 [1.146-1.958] 0.003      
   Depression 1.777 [1.353-2.334] <0.001 
   Diabetes 1.001 [0.773-1.297] 0.993      
   Epilepsy 1.520 [1.036-2.230] 0.032 
   Fibromyalgia 0.854 [0.448-1.628] 0.632      
   Gout 1.718 [1.188-2.483] 0.004      
   Hypercholesterolemia 0.965 [0.722-1.290] 0.810      
   Hyperlipidemia 0.796 [0.592-1.072] 0.133 
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   Hyperparathyroidism 0.496 [0.157-1.563] 0.231      
   Multiple Sclerosis 1.179 [0.551-2.524] 0.672      
   Osteoarthritis 1.204 [0.925-1.567] 0.167      
   Finger fracture 0.688 [0.359-1.319] 0.260       
   Hand Fracture 0.854 [0.424-1.723] 0.660 
   Radius or Ulnar fracture 1.495 [1.000-2.235] 0.050      
   Wrist fracture 1.665 [1.013-2.737] 0.044      
   Wrist sprain 1.386 [0.974-1.972] 0.070      
OR, odds ratio; 95% CI, 95% confidence interval 
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